Regulus Announces Pricing of Initial Public Offering

[at noodls] – LA JOLLA, CA, October 4, 2012 – Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today … more

View todays social media effects on ALNY

View the latest stocks trending across Twitter. Click to view dashboard